Co-Director BioTechMed-Graz

Begin of page section: Contents:

Univ.-Prof. Robert Krause



Department of Internal Medicine
Medical University of Graz
Auenbruggerplatz 15, 8036 Graz
Tel.: +43 316 385-81796


Prof. Robert Krause developed and expanded Clinical Infectious Diseases at Medical University of Graz. He is a physician scientist with special training in infectious diseases, internal medicine, and intensive care medicine. Prof. Krause investigates clinical aspects of fungal infections including biomarkers for earlier detection of fungal infections and risk stratification. Further topics of his research team include sepsis, foreign body associated infections, gastrointestinal infections, „antibiotic stewardship“ and „(re-) emerging infections“. Results of his team could be integrated in clinical routine and improved patient care, e.g. in patients with staphylococcus aureus bacteremia (final „Steirischer Qualitätspreis Gesundheit“). Currently his research group works on host-pathogen interactions in fungal infections and biomarker development in sepsis.
Prof Krause was President of the Austrian Society for Antimicrobial Chemotherapy (ÖGACH; 2016-2018) and is a board member of the Austrian Society for Infectious Diseases and Tropical Medicine and the ÖGACH. He was part of an EU project („abs-international“) and execute(d) projects funded by Austrian Research Promotion Agency (FFG) and the Austrian Science Fund (FWF).

Curriculum Vitae
since 2018 Co-Director of BioTechMed-Graz
since 2013 Professor for Clinical Infectious Diseases and Tropical Medicine, Medical University of Graz, Austria
Head, Section of Infectious Diseases and Tropical Medicine, Department of Internal Medicine, Medical University of Graz, Austria
since 2011 Member of the Faculty "Doctoral School for Sustainable Health Research, MUG"
University Docent, Department of Internal Medicine, Medical University of Graz, Austria (former part of University of Graz)
2011-2012 Chair of the science funding committee Medical University of Graz
2003 Habilitation in Internal Medicine, University of Graz, Austria
Residency, Department of Internal Medicine, education in Internal Medicine, Infectious Diseases, Intensive Care Medicine, University of Graz and Medical University of Graz, Austria

Diploma in hospital hygiene, Austrian Society for Microbiology

Trainee in the Department of Internal Medicine, Division of Infectious Diseases, Microbiological Laboratory, University of Graz, Austria
Dec 1990 M.D. graduation, University of Graz, Austria
1998 Diploma in Tropical Medicine and Medical Parasitology, Bernhard Nocht Institute, Hamburg, German
University education in human medicine, University of Graz, Austria
Other Positions
since 2007 Member of the executive committee of the Austrian Society for Infectious Diseases and Tropical Medicine
since 2016 President of the Austrian Society for Antimicrobial Chemotherapy
2008-2010  working group leader of the Austrian Society for Pneumology



2016 Österreichischer Infektionspreis 2016 (senior-author)
2015 Poster Award, Trends in Medical Mycology, European Confederation of Medical Mycology (ECMM) and EORTC Infectious Diseases Group (senior author)
2015 Award of Excellence, Award for best dissertation, Federal Ministry of Science, Research and Economy
2015 1. Poster Award, Theodor Escherich Symposium on Medical Microbiome Research (co-author)
2014 SALUS 2014 Steirischer Qualitätspreis Gesundheit (Finalist), Gesundheitsfonds Steiermark, project "Besserer Ausgang bei Staphylococcus aureus Bakteriämie"
2012 1. Poster Award, Österr. Ges. für Tropenmedizin und Parasitologie (co-author)
2012 Poster Award, 4th Annual Conference ÖGLMKC (senior-author)
2011 Researcher of the year 2011, Medical University of Graz
2008 2. Abstract Award (senior-author), Österr. Gesellschaft für Infektionskrankheiten
2008 Poster Award (senior-author), Österr. Gesellschaft für Innere Medizin
2008 3. Abstract Award (senior-author), Österr. Gesellschaft für Infektionskrankheiten
2007 2. Abstract Award (senior-author), Österr. Gesellschaft für Infektionskrankheiten
2003 Infektionspreis (2nd place), Österr. Gesellschaft für Chemotherapie
2001 Infektionspreis (2nd place), Österr. Gesellschaft für Infektionskrankheiten

Selected Publications

  • Prattes, J; Schneditz, D; Prüller, F; Jaindl, E; Sauseng, N; Hoenigl, M; Schilcher, G; Krause, R. 1, 3-ß-d-Glucan testing is highly specific in patients undergoing dialysis treatment. J Infect. 2017; 74(1):72-80
  • de With, K; Allerberger, F; Amann, S; Apfalter, P; Brodt, HR; Eckmanns, T; Fellhauer, M; Geiss, HK; Janata, O; Krause, R; Lemmen, S; Meyer, E; Mittermayer, H; Porsche, U; Presterl, E; Reuter, S; Sinha, B; Strauß, R; Wechsler-Fördös, A; Wenisch, C; Kern, WV. Strategies to enhance rational use of antibiotics in hospital: a guideline by the German Society for Infectious Diseases. Infection. 2016; 44(3):395-439
  • Krause, R; Halwachs, B; Thallinger, GG; Klymiuk, I; Gorkiewicz, G; Hoenigl, M; Prattes, J; Valentin, T; Heidrich, K; Buzina, W; Salzer, HJ; Rabensteiner, J; Prüller, F; Raggam, RB; Meinitzer, A; Moissl-Eichinger, C; Högenauer, C; Quehenberger, F; Kashofer, K; Zollner-Schwetz, I. Characterisation of Candida within the Mycobiome/Microbiome of the Lower Respiratory Tract of ICU Patients. PLoS One. 2016; 11(5):e0155033-e0155033
  • Krause, R; Zollner-Schwetz, I; Salzer, HJ; Valentin, T; Rabensteiner, J; Prüller, F; Raggam, R; Meinitzer, A; Prattes, J; Rinner, B; Strohmaier, H; Quehenberger, F; Strunk, D; Heidrich, K; Buzina, W; Hoenigl, M. Elevated levels of interleukin 17A and kynurenine in candidemic patients, compared with levels in noncandidemic patients in the intensive care unit and those in healthy controls. J Infect Dis. 2015; 211(3):445-451
  • Rabensteiner, J; Theiler, G; Duettmann, W; Zollner-Schwetz, I; Hoenigl, M; Valentin, T; Leitner, E; Luxner, J; Grisold, A; Valentin, A; Neumeister, P; Krause, R. Detection of central venous catheter-related bloodstream infections in haematooncological patients. Eur J Clin Invest. 2015; 45(8):824-832
  • Hoenigl, M; Duettmann, W; Raggam, RB; Huber-Krassnitzer, B; Theiler, G; Seeber, K; Prueller, F; Zollner-Schwetz, I; Prattes, J; Wagner, J; Wölfler, A; Krause, R. Impact of structured personal on-site patient education on low posaconazole plasma concentrations in patients with haematological malignancies. Int J Antimicrob Agents. 2014; 44(2):140-144
  • Hoenigl, M; Raggam, RB; Wagner, J; Prueller, F; Grisold, AJ; Leitner, E; Seeber, K; Prattes, J; Valentin, T; Zollner-Schwetz, I; Schilcher, G; Krause, R. Procalcitonin fails to predict bacteremia in SIRS patients: a cohort study. Int J Clin Pract. 2014; 68(10):1278-1281
  • Hoenigl, M; Wagner, J; Raggam, RB; Prueller, F; Prattes, J; Eigl, S; Leitner, E; Hönigl, K; Valentin, T; Zollner-Schwetz, I; Grisold, AJ; Krause, R. Characteristics of hospital-acquired and community-onset blood stream infections, South-East Austria. PLoS One. 2014; 9(8):e104702-e104702
  • Pruller, F; Wagner, J; Raggam, RB; Hoenigl, M; Kessler, HH; Truschnig-Wilders, M; Krause, R. Automation of serum (1 -> 3)-beta-D-glucan testing allows reliable and rapid discrimination of patients with and without candidemia. MED MYCOL. 2014; 52(5): 455-461.
  • Schilcher, G; Schneditz, D; Ribitsch, W; Horina, JH; Hoenigl, M; Valentin, T; Rosenkranz, AR; Krause, R. Loss of antimicrobial effect of trisodium citrate due to 'lock' spillage from haemodialysis catheters. Nephrol Dial Transplant. 2014; 29(4):914-919
  • Buyle, FM; Metz-Gercek, S; Mechtler, R; Kern, WV; Robays, H; Vogelaers, D; Struelens, MJ. members of the Antibiotic Strategy International (ABS) Quality Indicators Team Development and validation of potential structure indicators for evaluating antimicrobial stewardship programmes in European hospitals. Eur J Clin Microbiol Infect Dis. 2013; 32(9):1161-1170 

  • Hoenigl, M; Duettmann, W; Raggam, RB; Seeber, K; Troppan, K; Fruhwald, S; Prueller, F; Wagner, J; Valentin, T; Zollner-Schwetz, I; Wölfler, A; Krause, R. Potential factors for inadequate voriconazole plasma concentrations in intensive care unit patients and patients with hematological malignancies. Antimicrob Agents Chemother. 2013; 57(7):3262-3267

All Publications

End of this page section.
Go to overview of page sections.

Cooperating partners

 Universität Graz  TU Graz  Med-Uni Graz 

Begin of page section:

BioTechMed-Graz Coordination Office

Mozartgasse 12/II
8010 Graz

Mobile:+43 664 30 10 141

Mag. Julia Rohrer

Phone:+43 316 380 - 5022

Margit List-Schleich, MA

Phone:+43 316 380 - 5020

MMag. Christina Prix

Phone:+43 316 380 - 5022
In maternity leave

End of this page section.
Go to overview of page sections.